Analysis of irrational medical orders in pharmacy intravenous admixture services of a tertiary hospital
Liu Xiyu，Xiao Ming2，Luo Yongchuan3，Li Yuchen4，Lü Jiantao3
1 School of Pharmacy, Binzhou Medical University，Yantai 264003，China;
2 Weifang Eye Hospital，Weifang 261000，China;
3 Yantai Affiliated Hospital of Binzhou Medical University，Yantai 264100，China;
4 School of Pharmacy，Yantai University，Yantai 264005，China
Objective To classify and analyze irrational drug use in pharmacy intravenous admixture services (PIVAS) of a tertiary hospital, and to provide a reference for improving the rational use of drugs and ensuring the drug use safety of patients.Methods A retrospective survey method was used to sort out the long-term medical orders of a hospital from January 2018 to August 2021, classify irrational medical orders, and analyze the situation of irrational drug use.Results Among the 490 269 long-term medical orders, there were 2 739 irrational medication orders, of which the number of irrational long-term medical orders in 2019 was the largest. Among the types of long-term medical orders for irrational drug use, the top 3 errors in issuing-medical- orders were that drugs and solvents were not grouped together (8.21%), the number of changes made by physicians (1.79%), and the repeated issuing of medical orders (0.33%). The top three errors without prescriptions of doctors were irrational selection of solvent types (32.06%), irrational selection of solvent dosage (19.46%) and inappropriate drug dose (16.43%).Conclusion Prescription pharmacists use professional pharmaceutical knowledge, relevant laws and regulations and medication system software to carefully review the contents of prescriptions or medical orders, timely intervene and find unreasonable drug use, so as to reduce the occurrence of adverse drug reactions and improve the safety and effectiveness of drugs.
刘玺玉，肖明，罗永川，李雨晨，吕剑涛. 某三甲医院静脉用药调配中心不合理医嘱分析[J]. 中国医院统计, 2022, 29(4): 292-296.
Liu Xiyu，Xiao Ming，Luo Yongchuan，Li Yuchen，Lü Jiantao. Analysis of irrational medical orders in pharmacy intravenous admixture services of a tertiary hospital. journal1, 2022, 29(4): 292-296.
［1］王振敏，闫涛．2019—2020年某院静脉药物配置中心不合理医嘱分析［J］．中国处方药，2021，19(1)：65-66．
［2］国家药典委员会．中华人民共和国药典：2005年版2部［M］．北京：化学工业出版社，2005．
［3］吴永佩，焦雅辉．临床静脉用药调配与使用指南［M］．北京：人民卫生出版社，2010．
［4］宗希乙，沈建平．432种静脉注射剂临床配伍应用检索表［M］．北京：人民军医出版社，2011．
［5］黄俊．静脉用药调配中心不合理用药医嘱分析［J］．中国处方药，2020，18(11)：52-53．DOI:10.3969/j.issn.1671-945X.2020.11.028.
［6］MEHTA A M, VAN DEN HOVEN J M, ROSING H, et al. Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy［J］. Int J Pharm, 2015, 479(1):23-27. DOI:10.1016/j.ijpharm.2014.12.025.
［7］黄享贞，温坚坤，陈伟钊．静脉用药调配中心2219条不合理医嘱分析［J］．中国医学创新，2021，18(26)：181-184．DOI:10.3969/j.issn.1674-4985.2021.26.044.
［8］陆萍，倪东杰，郭良君，等．2017—2018年某医院骨科和普外科围术期患者解热镇痛药物利用分析［J］．中国医院统计，2020，27(1)：43-46．DOI:10.3969/j.issn.1006-5253.2020.01.008.
［9］施芳红，李浩，王怡，等．我院2013—2014年静脉药物超说明书用药分析［J］．中国药房，2015，26(29)：4060-4062．DOI:10.6039/j.issn.1001-0408.2015.29.10.
［10］何丽芳，陈成辉．非甾体抗炎药物的临床使用及其所致不良反应分析［J］．抗感染药学，2017，14(9)：1730-1732．DOI:10.13493/j.issn.1672-7878.2017.09-033.
［11］吴丽丽，韦超河，全耀威．我院静脉用药调配中心不合理医嘱分析［J］．临床合理用药杂志，2021，14(14)：136-138．DOI:10.15887/j.cnki.13-1389/r.2021.14.060.
［12］袁芳．某院2017年静脉配置中心不合理医嘱分析［J］．中医药管理杂志，2018，26(22)：28-30．DOI:10.16690/j.cnki.1007-9203.2018.22.015.
［13］黄庄霖，王惠颖．临床不合理用药现状分析与干预对策［J］．北方药学，2020，17(2)：178-179．DOI:10.3969/j.issn.1672-8351.2020.02.129.
［14］李玉堂，杨昌云，李炎丹，等．超说明书用药的审核分级与综合处理［J］．中国药房，2011，22(17)：1574-1576．
［15］卢静．医院药房中药注射液不合理应用调查及精细化管理模式的效果观察［J］．中国老年保健医学，2020，18(2)：154-155．DOI:10.3969/j.issn.1672-2671.2020.02.062.
［16］段少华，张霞，杨惠荔，等．基于三级公立医院绩效考核的医院质量管理改进与探讨［J］．中国医院统计，2021，28(5)：462-466．DOI:10.3969/j.issn.1006-5253.2021.05.018.
［17］陈晓瑾，廖莉，许宇璐，等．HIS预设联合用药规则设计提高儿童用药合理性的评价［J］．中国现代应用药学，2018，35(2)：280-283．DOI:10.13748/j.cnki.issn1007-7693.2018.02.029.
